Cargando…
Treatment of an adrenomyeloneuropathy patient with Lorenzo's oil and supplementation with docosahexaenoic acid-A case report
This is a case report of adrenomyeloneuropathy (AMN), the adult variant of adrenoleukodystryphy (ALD). The diagnoses in the patient, aged 34, was confirmed via increased serum very long chain fatty acid concentration (VLCFA). Treatment started with the cholesterol lowering drug, atorvastatin, follow...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3177782/ https://www.ncbi.nlm.nih.gov/pubmed/21871076 http://dx.doi.org/10.1186/1476-511X-10-152 |
_version_ | 1782212326064128000 |
---|---|
author | Terre'Blanche, Gisella van der Walt, Mietha M Bergh, Jacobus J Mienie, Lodewyk J |
author_facet | Terre'Blanche, Gisella van der Walt, Mietha M Bergh, Jacobus J Mienie, Lodewyk J |
author_sort | Terre'Blanche, Gisella |
collection | PubMed |
description | This is a case report of adrenomyeloneuropathy (AMN), the adult variant of adrenoleukodystryphy (ALD). The diagnoses in the patient, aged 34, was confirmed via increased serum very long chain fatty acid concentration (VLCFA). Treatment started with the cholesterol lowering drug, atorvastatin, followed by add-on therapy with Lorenzo's oil (LO) and finally supplementation with docosahexaenoic acid (DHA). The magnetic resonance imaging (MRI) scan of the AMN patient before DHA treatment, already showed abnormal white matter in the brain. Although the MRI showed no neurological improvement after 6 months of DHA treatment, no selective progression of demyelination was detected in the AMN patient. Contrary to what was expected, LO failed to sustain or normalize the VLCFA levels or improve clinical symptoms. It was however, shown that DHA supplementation in addition to LO, increased DHA levels in both plasma and red blood cells (RBC). Additionally, the study showed evidence that the elongase activity in the elongation of eicosapentaenoic acid (EPA) to docosapentaenoic acid (DPA) might have been significantly compromised, due to the increased DHA levels. |
format | Online Article Text |
id | pubmed-3177782 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-31777822011-09-22 Treatment of an adrenomyeloneuropathy patient with Lorenzo's oil and supplementation with docosahexaenoic acid-A case report Terre'Blanche, Gisella van der Walt, Mietha M Bergh, Jacobus J Mienie, Lodewyk J Lipids Health Dis Short Report This is a case report of adrenomyeloneuropathy (AMN), the adult variant of adrenoleukodystryphy (ALD). The diagnoses in the patient, aged 34, was confirmed via increased serum very long chain fatty acid concentration (VLCFA). Treatment started with the cholesterol lowering drug, atorvastatin, followed by add-on therapy with Lorenzo's oil (LO) and finally supplementation with docosahexaenoic acid (DHA). The magnetic resonance imaging (MRI) scan of the AMN patient before DHA treatment, already showed abnormal white matter in the brain. Although the MRI showed no neurological improvement after 6 months of DHA treatment, no selective progression of demyelination was detected in the AMN patient. Contrary to what was expected, LO failed to sustain or normalize the VLCFA levels or improve clinical symptoms. It was however, shown that DHA supplementation in addition to LO, increased DHA levels in both plasma and red blood cells (RBC). Additionally, the study showed evidence that the elongase activity in the elongation of eicosapentaenoic acid (EPA) to docosapentaenoic acid (DPA) might have been significantly compromised, due to the increased DHA levels. BioMed Central 2011-08-26 /pmc/articles/PMC3177782/ /pubmed/21871076 http://dx.doi.org/10.1186/1476-511X-10-152 Text en Copyright ©2011 Terre'Blanche et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Short Report Terre'Blanche, Gisella van der Walt, Mietha M Bergh, Jacobus J Mienie, Lodewyk J Treatment of an adrenomyeloneuropathy patient with Lorenzo's oil and supplementation with docosahexaenoic acid-A case report |
title | Treatment of an adrenomyeloneuropathy patient with Lorenzo's oil and supplementation with docosahexaenoic acid-A case report |
title_full | Treatment of an adrenomyeloneuropathy patient with Lorenzo's oil and supplementation with docosahexaenoic acid-A case report |
title_fullStr | Treatment of an adrenomyeloneuropathy patient with Lorenzo's oil and supplementation with docosahexaenoic acid-A case report |
title_full_unstemmed | Treatment of an adrenomyeloneuropathy patient with Lorenzo's oil and supplementation with docosahexaenoic acid-A case report |
title_short | Treatment of an adrenomyeloneuropathy patient with Lorenzo's oil and supplementation with docosahexaenoic acid-A case report |
title_sort | treatment of an adrenomyeloneuropathy patient with lorenzo's oil and supplementation with docosahexaenoic acid-a case report |
topic | Short Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3177782/ https://www.ncbi.nlm.nih.gov/pubmed/21871076 http://dx.doi.org/10.1186/1476-511X-10-152 |
work_keys_str_mv | AT terreblanchegisella treatmentofanadrenomyeloneuropathypatientwithlorenzosoilandsupplementationwithdocosahexaenoicacidacasereport AT vanderwaltmietham treatmentofanadrenomyeloneuropathypatientwithlorenzosoilandsupplementationwithdocosahexaenoicacidacasereport AT berghjacobusj treatmentofanadrenomyeloneuropathypatientwithlorenzosoilandsupplementationwithdocosahexaenoicacidacasereport AT mienielodewykj treatmentofanadrenomyeloneuropathypatientwithlorenzosoilandsupplementationwithdocosahexaenoicacidacasereport |